Show simple item record

dc.contributor.authorTroelsen, Lone N.
dc.contributor.authorJacobsen, Soren
dc.contributor.authorAbrahams, Jodie L.
dc.contributor.authorRoyle, Louise
dc.contributor.authorRudd, Pauline M.
dc.contributor.authorNarvestad, Eva
dc.contributor.authorHeegaard, Niels H.
dc.contributor.authorGarred, Peter
dc.date.accessioned2017-08-11T03:21:30Z
dc.date.available2017-08-11T03:21:30Z
dc.date.issued2012
dc.identifier.issn0315-162X
dc.identifier.doi10.3899/jrheum.110584
dc.identifier.urihttp://hdl.handle.net/10072/343819
dc.description.abstractObjective. To examine whether IgG glycosylation changes and MBL2 genotypes are associated with systemic inflammation and joint destruction in rheumatoid arthritis (RA). Methods. IgG N-glycan content was determined from serum in 118 patients with RA by high-throughput glycan analysis using normal-phase high-pressure liquid chromatography. MBL2 extended genotypes (YA/YA, YA/XA, XA/XA, YA/YO, XA/YO, YO/YO) were determined. Systemic inflammation was assessed by serum levels of C-reactive protein (CRP), interleukin 6 (IL-6), and tumor necrosis factor-α (TNF-α). Joint destruction was assessed by total Sharp score (TSS) and alloplastic surgery records. Results. IgG hypogalactosylation was significantly correlated to IL-6 (Spearman’s rho = 0.32, p < 0.001), CRP (Spearman’s rho = 0.31, p < 0.001), TSS (Spearman’s rho = 0.25, p = 0.01), and alloplastic replacement of joints (Spearman’s rho = 0.18, p = 0.05). In multivariate analysis including age, CRP, anticitrullinated protein antibodies (ACPA), and other confounders, IgG hypogalactosylation was significantly associated with TSS (p = 0.014) and alloplastic joint replacement (OR 76.5, p = 0.041) in patients homozygous for the high expression MBL2 genotype YA/YA, but not in carriers of lower expression genotypes. Conclusion. Decreased galactosylation of IgG correlated to markers of inflammation, i.e., IL-6 and CRP. Only in patients homozygous for high expression of the MBL2 genotype YA/YA was IgG hypogalactosylation associated with markers of joint destruction. Our results suggest that inflammation-associated decreased galactosylation of IgG combined with high expression MBL2 genotypes are involved in the pathophysiology of RA.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherJournal of Rheumatology Publishing
dc.relation.ispartofpagefrom463
dc.relation.ispartofpageto469
dc.relation.ispartofissue3
dc.relation.ispartofjournalJournal of Rheumatology
dc.relation.ispartofvolume39
dc.subject.fieldofresearchImmunology not elsewhere classified
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode110799
dc.subject.fieldofresearchcode1103
dc.subject.fieldofresearchcode1107
dc.subject.fieldofresearchcode1117
dc.titleIgG glycosylation changes and MBL2 polymorphisms: Associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorAbrahams, Jodie L.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record